Clinical Trial Update: Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating bexarotene for preventing breast cancer in high-risk individuals; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Atypical Ductal Hyperplasia
• Breast Atypical Lobular Hyperplasia
• Breast Cancer Prevention in High-risk Individuals
• Breast Ductal Carcinoma in Situ
• Breast Lobular Carcinoma in Situ
• Invasive Breast Carcinoma

Drugs mentioned

• Bexarotene (Bexarotene)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia | Phase 1 | Status: COMPLETED | Results posted: 2022-12-06